Wegovy, a weight-loss medication previously available through limited routes, is now available in the UK through pharmacies both online and in high street stores. Multiple outlets report the roll-out includes community pharmacy supply, and that patients can access the oral product from today, with some coverage describing a further opening window as the wider availability begins. Coverage also highlights uncertainty about how eligibility works, with particular attention on who qualifies for treatment.
Reporting notes the transition is expected to drive high demand, with some outlets describing a potential “stampede” as tens of thousands of people seek access. In addition, at least one outlet says pharmacies are concerned about possible increases in counterfeit or unsafe fake versions if demand outpaces legitimate supply.
Other articles reference pricing and access issues, including how NHS patients may experience longer waits compared with private routes. Overall, the coverage focuses on the start of retail and online availability, the criteria for patients, expected demand pressure, and measures needed to reduce the risk of counterfeit medicines.
